Bilirubin

Robert Öllinger; Martin Bilban; Anna Erat; Alberto Froio; James McDaid; Shivraj Tyagi; Eva Csizmadia; Aurélio V. Graça-Souza; A Liloia; Miguel P. Soares; Leo E. Otterbein; Anny Usheva; Kenichiro Yamashita; Fritz H. Bach

doi:10.1161/circulationaha.104.528802

August 9, 2005CirculationOpen Access

Bilirubin

View Full Paper

Ask AI

Bookmark

Share

Key result

Bilirubin and biliverdin show potential therapeutic activity for vascular proliferative disorders.

Key Points

Assess the potential role and therapeutic viability of bilirubin and biliverdin in the management of vascular proliferative disorders.
Evaluated the biological and pharmacological actions of the bile pigments bilirubin and biliverdin in the context of vascular tissue growth.
Identified bilirubin and biliverdin as candidate therapeutics capable of targeting vascular proliferative pathology.
Suggested that bile pigments may modulate abnormal vascular cell proliferation to provide vascular protection.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Scientific review highlights the therapeutic potential of bilirubin and biliverdin in vascular proliferative disorders, suggesting novel treatment strategies for blood vessel diseases.

Abstract

Bilirubin and biliverdin might be potential therapeutics in vascular proliferative disorders.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Öllinger et al. (2005) studied this question. Bilirubin and biliverdin might serve as potential therapeutics for the treatment of vascular proliferative disorders.

synapsesocial.com/papers/69dbcb9437b5141e3ba3d473 https://doi.org/10.1161/circulationaha.104.528802

View Full Paper

Ask AI

Bookmark

Share

Bilirubin

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Bilirubin

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading